Series: Advancing Precision Medicine (APM) • Advancing Precision Oncology (APO) • Advancing Pathology Education (APE)
What it is: A two-day, multi-track conference uniting leaders across oncology, pathology, data science and clinical development to translate multi-omics + AI into patient impact. The program combines keynotes, parallel sessions, non-CME industry spotlights, exhibits, and networking.
Co-Chairs: Andrea Ferreira-Gonzalez • Wafik S. El-Deiry, MD, PhD, FACP (WIN Chair; Legorreta Cancer Center, Brown University) • Razelle Kurzrock, MD (WIN CMO; MCW Cancer Center)
Keynote: William G. Kaelin, Jr., MD (2019 Nobel Laureate; Harvard/Dana-Farber) — Targeting the Achilles’ Heel of Cancer: Synthetic Lethality and Hypoxia in Precision Oncology
🎯 Who should attend: Oncologists, pathologists, translational researchers, data scientists, trialists, diagnostics and biopharma leaders.
Program Highlights
- Multi-Omics + AI in Precision Oncology: Clinical decision support, integration of real-world data, and next-gen analytics with leaders from Caris Life Sciences, MGH/Harvard, and ConcertAI.
- Spatial & Single-Cell: Applications and technology perspectives featuring scientists from Yale, Harvard/Weill Cornell, 10x Genomics, and Gilead.
- MRD, Liquid Biopsy & Molecular Monitoring: GI oncology applications and real-world adoption with experts from City of Hope and UC San Diego.
- Tumor Plasticity & Resistance: EMT, evolutionary modeling, and translational challenges (Cleveland Clinic, Brown University).
- From Targets to Trials: Early-phase precision trials, immuno-oncology beyond checkpoints, and venture philanthropy.
- AI & Digital Pathology: Clinical and industry perspectives (Genentech, Roche Diagnostics, PathAI).
- Pediatric Precision Oncology: Impact-driven advances with leaders from Penn State, Wake Forest, UF Health, Mount Sinai, and Caris.
- Global Access & Implementation: Building precision oncology infrastructure in LMICs and live WIN international molecular tumor board.
Parallel Tracks: Track 1 (204BC) and Track 2 (204A) run throughout with sessions on multi-omics, spatial biology, AI & digital pathology, and clinical translation. Non-CME industry sessions punctuate both days, plus exhibits and networking receptions.
🗓️ Day 1 (Friday): Keynote (Kaelin) • AI + Omics • Spatial-Omics • MRD & Evolution of Precision • Trials & Immunotherapy • Pediatric Oncology • Liquid Biopsy • Industry Spotlights • Reception
🗓️ Day 2 (Saturday): Welcome & recap • Keynote • Precision outside oncology • Global access and implementation • KRAS, epigenetic plasticity • Molecular pathology in GU cancers • Companion diagnostics & AI forums • WIN Consortium Update
🔗 Registration: Register Today • 💼 Become a Sponsor
📬 Questions? Contact the organizers via the APM site. Subscribe to the newsletter to receive program updates, speaker additions, and CE/CME details.